Good morning, one and all. Damian Garde here, filling in for Ed Silverman at the start of another working week, with the familiar crush of deadlines, appointments, and meetings, visual and otherwise. Here as always are some tidbits to get you started. Do let us know if you hear anything interesting.
Operation Warp Speed, the federal initiative to accelerate treatments and vaccines for Covid-19, looks a lot more like a military operation than a science project, according to STAT, which obtained the project’s organizational chart. Roughly 60 military officials — including at least four generals — are involved in the leadership of Operation Warp Speed, many of whom have never worked in health care or vaccine development. Just 29 of the roughly 90 leaders on the chart aren’t employed by the Department of Defense.
Johnson & Johnson’s (JNJ) experimental Covid-19 vaccine led to a positive immune reaction in a small, early-stage clinical trial, the Wall Street Journal tells us. The study, which has not yet been peer reviewed, enrolled nearly 800 volunteers, and found that J&J’s vaccine appeared safe. The company has already started a Phase 3 study that will recruit up to 60,000 participants.